➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Norepinephrine bitartrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for norepinephrine bitartrate and what is the scope of patent protection?

Norepinephrine bitartrate is the generic ingredient in three branded drugs marketed by Hospira, Amneal, Baxter Hlthcare Corp, Hikma, Metrics Pharm, Mylan Labs Ltd, Sandoz Inc, Teva Pharms Usa, West-ward Pharms Int, and Eastman Kodak, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for norepinephrine bitartrate. Eight suppliers are listed for this compound.

Drug Prices for norepinephrine bitartrate

See drug prices for norepinephrine bitartrate

Recent Clinical Trials for norepinephrine bitartrate

Identify potential brand extensions & 505(b)(2) entrants

University Tunis El ManarPhase 4
Samuel Lunenfeld Research Institute, Mount Sinai HospitalN/A

See all norepinephrine bitartrate clinical trials

Pharmacology for norepinephrine bitartrate
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for norepinephrine bitartrate

US Patents and Regulatory Information for norepinephrine bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 211242-001 Oct 4, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira LEVOPHED norepinephrine bitartrate INJECTABLE;INJECTION 007513-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
West-ward Pharms Int NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040462-001 Oct 31, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.